Sangamo Therapeutics

About:

Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.

Website: http://www.sangamo.com

Twitter/X: sangamotx

Top Investors: National Institutes of Health, California Institute for Regenerative Medicine

Description:

Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.